Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$DIDG is a steal at these levels!
Keep an eye out for $DIDG this week. Financials expected soon.
$DIDG has MJ media covered with MJ360.tv.
Keep an eye out for $DIDG over the next week. These are loading levels.
Good morning $DIDG!
I'm looking forward to the documentaries. The public needs the facts regarding MJ and Cannabis. I've seen a few MJ documentaries on CNN, but these need to be aggregated and hosted in one location. An MJ On Demand feature would be even better! $DIDG
It's about time a company dedicated a Website strictly to hosting MJ related media. Seems like a one stop shop for MJ entertainment. $DIDG
Movies, music, and WeeeeeD! $DIDG
Looks like today's $VRCI news addresses this major issue:
http://www.nytimes.com/2014/11/05/business/ebola-researchers-rush-to-find-a-fast-diagnostic-test.html?_r=1
Great loading opportunity! $VRCI
I thought the ask was already thin and then it just opened right up. .0021 straight to .0038! $SIPC
Gotta love the gaps, but they always get filled. Time to move back up! $VRCI
I want to see it blow past .0035 straight to .0060! Realistically it could happen as there is a lot of visibility here. $SIPC
$VRCI has Ebola news today! Lots of buys coming in. Look for a good entry here.
Nice early morning buys coming in! $VRCI
$VRCI and Ebola! Get ready!
$VRCI and Ebola! Enough said.
Good morning $SIPC
Good morning $VRCI
Mind taking a look at $VRCI? Looks like it may be in for a big week.
$VRCI...somethings up with it. Keep an eye out.
$VRCI is prepping for a tear this week. Multi-bagger alert!
Add $VRCI to your radar this week.
$VRCI deserves your attention this week.
$VRCI looking good this week. They're growing weed in India to avoid the legal and licensing nonsense in the US and Canada. Genius!
$VRCI is growing weed in India!!! We have a publicly traded ticker legally growing weed! Instead of dealing with the legal limitations, they bypassed them completely! Pure genius!
Keep an eye on $VRCI this week. Solid play ahead.
$VRCI looking strong as a multibagger play this week.
Locked and loaded! Buckled in for the ride! Hope folks have their running shoes on cause they might just be chasing this one. $VRCI
Verde Science is discussing possible collaborations with private companies that have applied for a Medical Marijuana R&D only license from Health Canada and are awaiting final approvals.
This expedited and low cost scientific approach sets Verde Science apart from most in the medical marijuana space, as the company has no intention to become a licensed marijuana grower/operator in Canada or the United States, nor does it intend to apply for a MMPR license with Health Canada.
The company’s scientists have already identified certain cannabis extracts they believe show distinct promise for further study. Research will begin in India where marijuana research is far less regulated, costs are lower and traditional Indian medicine has been advocating the use of marijuana to treat certain medical conditions for centuries.
The Verde Science approach is a pharmacological/medical study of cannabis extracts that actually have an effect on specific medical conditions, while minimizing any deleterious effects of smoking medical marijuana or inhaling vapors that have diminished its use in mainstream medicine
“This approach along with our synergistic and highly skilled team will streamline our processes and yield optimal results, without having to wait for a R&D license in Canada”, concluded Mr. Patel.
“We are immediately beginning the coordinated design of our overall R&D program with our front end and back end team members in India, so that all members of the team will be constantly in the feedback loop throughout the R&D process for each compound we are studying”, according to Manit Patel.
Sterkem Group – Verde Science and Sterkem Group (www.sterkempharma.com) a Mumbai, India based pharmaceutical research, production and marketing firm, are finalizing the plan for a pharmaceutical development venture that will refine the resultant cannabis-based extracts for specific medical conditions identified by Verde’s R&D program into deliverable and marketable pharmaceutical formulations.
The Institute of Chemical Technology – The ICT and Verde Science are moving toward an alliance that will offer expanded research capabilities for Verde’s ongoing scientific inquiries that will utilize faculty and graduate students to supplement Verde’s internal scientists.
Drs. Ratnesh Jain and Prajatka Dandekar Jain, Senior Researchers – Dr. Prajakta Jain has a Ph.D. in Bioprocess Technology with expertise in extraction and isolation of active ingredients from plants. Dr. Ratnesh Jain has a Ph.D. in nanocarriers and drug delivery systems. Both researchers are faculty at the Institute of Chemical Technology and will be pivotal to cost effective extraction, isolation and formulation design from the marijuana plant.
Manit Patel, CTO -- B.Sc. in Pharmaceutical Science from the Institute of Chemical Technology of Mumbai, India. MBA from Queensland University of Technology in Brisbane, Australia. Expertise in pharmaceutical research, product design, production, and business strategy and development, with a broad network of international business contacts. He has successfully launched 9 products for Sterkem during his tenure.
(OTCPK: VRCI) Verde Science, Inc., a Medical Research and Development Company, is pleased to announce that it has assembled its complete Research and Development team under the direction of its newly appointed Chief Technology Officer, Manit Patel, and it has initiated the coordinated design of its overarching R&D plan.